๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
A Study to Assess the Effectiveness and Safety of Ozanimod in Chinese Adults With Relapsing Multiple Sclerosis
NCT06396039Relapsing Multiple Sclerosis
Bristol-Myers Squibb
Phase 4
84
Beijing, Guangzhou, Shenzhen, Shijiazhuang, Harbin, Zhengzhou, Wuhan, Nanchang
2024-05-15
Recruiting
Clinical Trail of Neoadjuvant of Tislelizumab Combined With Palbociclib in Patients With Platinum-refractory Bladder Urothelial Carcinoma
NCT06364956Bladder Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 1/2
36
Guangzhou, Wuhan, Changsha
2024-05-15
Recruiting
Prebiotics and the Management of Hyperuricemia
NCT06420401Subjects With Hyperuricemia
Sun Yat-sen University
Not applicable
160
Guangzhou
2024-05-15
Recruiting
Cellular Immunotherapy for Relapsed or Refractory Lymphoma Data Collection
NCT06541327Lymphoma, Non-Hodgkin
Ruijin Hospital
Observational
1,000
Shanghai
2024-05-15
Recruiting
A Study of JMT203 in Patients With Cancer Cachexia
NCT06868849Non Small Cell Lung Cancer, Pancreatic Cancer, Cancer Cachexia, Colorectal Cancer Cachexia
Shanghai JMT-Bio Inc.
Phase 1/2
307
Zhejiang
2024-05-15
Active, closed
A Comparative Study of Neoadjuvant Chemotherapy Versus Upfront Radical Surgery for Upper Tract Urothelial Carcinoma
NCT07155044UTUC, UC (Urothelial Cancer)
Changhai Hospital
Observational
120
Shanghai
2024-05-15
Active, closed
Nimotuzumab Plus NALIRIFOX in Locally Advanced Pancreatic Cancer
NCT06429904Locally Advanced Pancreatic Cancer
Peking Union Medical College Hospital
Phase 2
31
Beijing
2024-05-15
Recruiting
Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma
NCT06406634Hepatocellular Carcinoma
Hunan Cancer Hospital
Phase 2
30
Changsha
2024-05-15
Recruiting
The Safety and Effectiveness of NEPA in Preventing Postoperative Nausea and Vomiting After General Anesthesia Gastrointestinal Cancer Surgery: A Single-Center Retrospective Study
NCT06417567General Anesthesia Gastrointestinal Cancer Surgery
Tianjin Medical University Cancer Institute and Hospital
Observational
50
Tianjin
2024-05-15
Recruiting
ICP-248 in Combination With Orelabrutinib in Treatment-naรฏve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (APEX-03)
NCT06378138Hematologic Malignancies
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 2/3
226
Bengbu, Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Guangzhou
2024-05-15
Recruiting
Biomarkers and Molecular Mechanism Study of Hepatocellular Carcinoma After Radical Resection and Conversion Therapy
NCT06382103Hepatocellular Carcinoma
Shanghai Zhongshan Hospital
Observational
240
Shanghai
2024-05-15
Recruiting
Clinical Outcome in Patients With INPH
NCT06428734Hydrocephalus, Idiopathic Normal Pressure Hydrocephalus, CSF, Glympathic System
Xuanwu Hospital, Beijing
Observational
200
Beijing
2024-05-15
Recruiting
Thalidomide Therapy for VEOIBD
NCT06382519Inflammatory Bowel Diseases
Children's Hospital of Fudan University
Observational
40
Shanghai
2024-05-15
Recruiting
Analysis of Deep Brain Nuclei LFP and Cortical EEG Signals During the Recovery From General Anesthesia
NCT06400901Deep Brain Stimulation Surgery, Electrophysiology, General Anesthesia, Consciousness, Loss of
Ruijin Hospital
Observational
42
Shanghai
2024-05-15
Not yet open
A Study of RJMty19 in Refractory Systemic Lupus Erythematosus (SLE)
NCT06340490Systemic Lupus Erythematosus
Guangdong Ruishun Biotech Co., Ltd
Phase 1
24
Beijing, Nanjing, Shanghai
2024-05-15
Recruiting
Tislelizumab in Combination With GP or TPC Regimen for the Treatment of Nasopharyngeal Carcinoma With Bone Metastasis.
NCT06383780Nasopharyngeal Carcinoma
XIANG YANQUN
Phase 3
90
Guangzhou
2024-05-15
Active, closed
INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPSโ‰ฅ20 HNSCC
NCT06295731Head and Neck Squamous Cell Carcinoma (HNSCC)
Inhibrx Biosciences, Inc
Phase 2/3
410
2024-05-14
Active, closed
Phase 3 Study of ALXN1850 in Treatment-Naรฏve Pediatric Participants With HPP
NCT06079359Hypophosphatasia
Alexion Pharmaceuticals, Inc.
Phase 3
30
Beijing, Guangzhou, Shanghai, Shenzhen
2024-05-14
Recruiting
Identification for High Risk of Coronary Heart Disease Based on Quantitative Analysis of Fundus Vessels and Metabolic Molecules
NCT07773064Coronary Artery Disease
Beijing Hospital
Observational
3,000
Beijing
2024-05-14
Recruiting
Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCT
NCT06202625Thrombocytopenia, Stem Cell Transplant Complications
Peking University People's Hospital
Phase 2/3
142
Beijing, Guangzhou, Shenzhen, Harbin, Zhengzhou, Wuhan, Changsha, Nanchang
2024-05-13
Recruiting
A Phase 3 Multinational Study of Golidocitinib Versus Investigator's Choice in r/r PTCL (JACKPOT19)
NCT07234162Peripheral T-cell Lymphoma
Dizal Pharmaceuticals
Phase 3
218
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Guangzhou, Nanning
2024-05-13
By invitation
Electroencephalogram Characteristics of Surgical Anesthetized Patients and Postoperative Dilirium
NCT06394778Electroencephalogram, Postoperative Delirium (POD)
First Affiliated Hospital of Zhejiang University
Observational
375
Hangzhou
2024-05-13
Recruiting
Central-boost Ablative Radiation Therapy for Solid Tumors (CBART)
NCT06427460Pancreatic Cancer
Changhai Hospital
Phase 2
67
Shanghai
2024-05-12
Recruiting
Clinical Study of GT201 in Combination With PD-1 Inhibitor for Advanced Head and Neck Tumors
NCT06190275HNSCC
Grit Biotechnology
Not applicable
32
Shanghai
2024-05-12
Active, closed
An Open-label Study of a Gene Therapy Product (Vebeglogene Autotemcel) in Transfusion Dependent Beta-Thalassemia
NCT06308159Beta-Thalassemia
Lantu Biopharma
Phase 1/2
6
Kunming
2024-05-11
Recruiting
Study on the Mechanism of Yifei Moxibustion Improving Immune Function in COPD Based on Plasma Exosome miRNAs
NCT07131020Stable COPD Patients
Henan University of Traditional Chinese Medicine
Not applicable
120
Zhengzhou
2024-05-11
Recruiting
MRD-positive AML Clinical Study
NCT07131059AML, Adult
Institute of Hematology & Blood Diseases Hospital, China
Not applicable
537
Tianjin
2024-05-11
Recruiting
Research on the Safety and Efficacy of Blocking Dural Blood Supply in Glioblastoma Patients
NCT05990556Glioblastoma, Meningeal Arteries
First Affiliated Hospital, Sun Yat-Sen University
Not applicable
20
Guangzhou
2024-05-11
Recruiting
Lenvatinib Combined With TACE and Camrelizumab in Conversion Resection for Advanced Hepatocellular Carcinoma (LEN-TAC Study)
NCT05738616Advanced Hepatocellular Carcinoma
Wen Tianfu
Phase 3
196
Chengdu
2024-05-10
Recruiting
GPC3/Mesothelin-CAR-ฮณฮดT Cells Against Cancers
NCT06196294Pancreas Cancer, Lung Cancer, Liver Cancer, Mesothelioma
Second Affiliated Hospital of Guangzhou Medical University
Phase 1
30
Guangzhou
2024-05-10
By invitation
Effects of Unilateral, Bilateral and Combined Resistance Training on the Speed and Accuracy of the Serve in Youth Tennis Players
NCT06419452Exercise Training
Universiti Putra Malaysia
Not applicable
56
Lanzhou
2024-05-10
Recruiting
Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Breast Cancer
NCT06411678Breast Cancer
Peking Union Medical College Hospital
Phase EARLY_PHASE1
50
Dongcheng
2024-05-10
Recruiting
Probiotics Combined with Enteral Nutrition Reduces Postoperative Infectious Complications in PD
NCT06719596Infectious Complications
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 1/2
68
Nanjing
2024-05-10
Recruiting
Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 3 Patients
NCT06421831Spinal Muscular Atrophy Type 3
GeneCradle Inc
Phase 1/2
21
Beijing
2024-05-10
Recruiting
Camrelizumab Plus Fluzoparib for TP-53 Mutated Endometrial Cancer
NCT06413992Endometrial Carcinoma, TP53 Mutation, Recurrent or Metastatic
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
117
Beijing
2024-05-10
By invitation
Exploring the Minimum Effective Concentration and Volume of Ropivacaine for Sacral Plexus Anesthesia
NCT06711679Pediatric ALL
Yilin Zhao
Phase 4
180
Wuhan
2024-05-10
Not yet open
Multiple Study of Electroaccpuncture in ARDS
NCT06278675Acute Respiratory Distress Syndrome, Sepsis
Nanjing University of Traditional Chinese Medicine
Not applicable
264
Nanjing
2024-05-10
Recruiting
SHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer
NCT06394492Ovarian Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
440
Beijing, Hangzhou
2024-05-10
Recruiting
[18F]AV45(Aฮฒ) and [18F]AV1451(Tau)PET/CT in the Diagnosis of Early Pathological Changes of Alzheimer's Disease
NCT06833645Alzheimer's Disease
Sichuan Provincial People's Hospital
Observational
280
Chengdu
2024-05-10
Recruiting
A Clinical Trial of SIBP-A13 Injection in the Treatment of Advanced Malignant Solid Tumor Patients.
NCT06298058Advanced Solid Tumor
Shanghai Institute Of Biological Products
Phase 1
144
Shanghai
2024-05-09
Recruiting
Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
NCT06395870B-Cell Non-Hodgkin Lymphoma-Recurrent, B-Cell Non-Hodgkin Lymphoma-Refractory
Tianjin Medical University Cancer Institute and Hospital
Phase 1
33
Hefei, Tianjin
2024-05-09
Recruiting
A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma
NCT06436677Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Cutaneous T Cell Lymphoma
Peking University First Hospital
Observational
100
Beijing
2024-05-09
Recruiting
Prognosis of Patients With Infective Endocarditis and Risk Stratification Value of Biomarkers (ENDEAVOR๏ผ‰
NCT05965362Infective Endocarditis
First Affiliated Hospital Xi'an Jiaotong University
Observational
2,000
Xi'an
2024-05-09
Active, closed
Real World Evidence in China: Faricimab Use in Diabetic Macular Edema, Retinal Vein Occlusion, and Neovascular Age-Related Macular Degeneration (The Farseeing Study)
NCT06439576Diabetic Macular Edema, Neovascular Age-related Macular Degeneration, Retinal Vein Occlusion
Hoffmann-La Roche
Observational
1,000
Shantou, Luoyang, Shiyan, Xuzhou, Fushun, Panjin, Shenyang, Weifang
2024-05-09
Recruiting
Risk Stratification and New Early Prevention and Treatment Strategies for Patients With Cardiomyopathy (STRENGTH๏ผ‰
NCT06352320Cardiomyopathies
First Affiliated Hospital Xi'an Jiaotong University
Observational
500
Xi'an
2024-05-09
Recruiting
Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer
NCT06289062Cervical Cancer, Neoadjuvant Chemoimmunotherapy, Fertility Preservation
Tongji Hospital
Phase 2
40
Guangzhou, Wuhan
2024-05-08
Recruiting
Short-course Radiotherapy Combined With CapeOx and PD-1 Inhibitor After Local Excision for High-risk Early Rectal Cancer (TORCH-LE)
NCT06455124Rectal Cancer
Fudan University
Phase 2
60
Shanghai
2024-05-08
Recruiting
Short Course Radiotherapy With Sequential Disitamab Vedotin Combined With S-1 and Sintilimab as Whole Course Neoadjuvant Therapy for HER2 Expressed Locally Progressive Gastric Cancer
NCT06487429Gastric Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2
28
Wuhan
2024-05-08
Recruiting
A Clinical Study of Purinostat Mesylate for Injection in Patients With Advanced Solid Tumors
NCT06431243Advanced Solid Tumor
Chengdu Zenitar Biomedical Technology Co., Ltd
Phase 1/2
132
Guanzhou, Chengdu
2024-05-08
Recruiting
Anti-cancer Neoantigen mRNA Vaccine to Treat Solid Tumors
NCT06195384Solid Tumor, Adult
Second Affiliated Hospital of Guangzhou Medical University
Phase 1
30
Guangzhou
2024-05-08
Active, closed
A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis
NCT06407934Dermatitis Atopic
Sanofi
Phase 3
1,541
Beijing, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Jinan
2024-05-08
Recruiting
Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS
NCT05795140Atypical Hemolytic Uremic Syndrome
Novartis Pharmaceuticals
Phase 3
65
Beijing
2024-05-08
Active, closed
A Clinical Trial Comparing Staged Turnbull-Cutait Pull-through Anastomosis With Direct Anastomosis Plus Prophylactic Ileostomy in the Treatment of Low Rectal Cancer After Internal Sphincter Resection
NCT06662643Rectal Cancer, Rectal Carcinoma
Zhongnan Hospital
Not applicable
110
Wuhan
2024-05-08
Recruiting
A Multicenter Open Clinical Study of Safety, Tolerability, Pharmacokinetic Profile, and Initial Clinical Efficacy of BAT 8010 for Injection Combined With BAT 1006 in the Treatment of Locally Advanced or Metastatic Tumors
NCT06376136Advanced Solid Tumors
Bio-Thera Solutions
Phase 1/2
216
Guangzhou
2024-05-08
Active, closed
A Study Comparing BL-M07D1 With T-DM1 in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer
NCT06316531HER2-positive Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
274
Guangzhou
2024-05-08
Recruiting
A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer
NCT06361888Metastatic Pancreatic Cancer
Hutchmed
Phase 2/3
502
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Shenzhen, Nanning, Guandong
2024-05-08
Not yet open
QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Early High-Risk TNBC Breast Cancer
NCT06404736Early Breast Cancer, Neoadjuvant Therapy, TNBC, Triple Negative Breast Cancer
Fudan University
Phase 2
73
Shanghai
2024-05-07
By invitation
A Clinical Study Evaluating the Safety and Efficacy of BioTTT001 in Patients With Malignant Solid Tumors
NCT06215846Solid Tumor
Beijing Bio-Targeting Therapeutics Technology Co., Ltd
Phase 1
12
Shenyang
2024-05-07
Recruiting
Evaluate the Safety and Efficacy of BGT007H Cell Therapy in Patients With Relapsed/Refractory Pancreatic Cancer
NCT06478225Tumor Pancreas
RenJi Hospital
Not applicable
12
Shanghai
2024-05-07
Recruiting
Clinical Efficacy of Tumour Treatment Vaccine (TTV) Combined With PD-1 in the Treatment of Relapsed Refractory Advanced Solid Tumours
NCT06430502Cancer, PD-L1 Gene Mutation
Wuxi People's Hospital
Not applicable
200
Wuxi
2024-05-07
Recruiting
The Impact and Effect of Traditional Chinese Medicine Treatment on Organ Failure in Critically Ill Patients
NCT06452966Organ Failure, Multiple, Indigestion, Delayed Gastric Emptying, Respiratory Failure
China Medical University Hospital
Not applicable
350
2024-05-07
Recruiting
PPIO-008 Tislelizumab Combined With S-1 in Patients With ypT+N0 ESCC After Radical Resection With Neoadjuvant STUDY
NCT06354140Esophageal Squamous Cell Carcinoma
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 2
45
Chongqing
2024-05-07
Recruiting
A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma(NHL)
NCT06446128Non-Hodgkin Lymphoma, B-cell
Shanghai Cell Therapy Group Co.,Ltd
Phase EARLY_PHASE1
20
Shanghai
2024-05-07
Recruiting
AMT-116 in Patients with Solid Tumors
NCT06782334Advanced Solid Tumors
Multitude Therapeutics Inc.
Phase 1/2
144
Fuzhou, Dongguan, Guangzhou, Nanning, Changsha, Hangzhou, Wenzhou
2024-05-07
Recruiting
A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease
NCT06300320Chronic Graft Versus Host Disease
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2
65
Hefei, Lanzhou, Guangzhou, Nanning, Shijiazhuang, Xiangyang, Taian, Shanghai
2024-05-07
Recruiting
Evaluate the Safety and Efficacy of Tafasitamab and Lenalidomide in Combination With Gemcitabine and Oxaliplatin Versus Rituximab in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
NCT06521255DLBCL
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 3
244
Beijing, Changchun, Changsha, Chaozhou, Chengdu, Chongqing, Guangzhou, Hangzhou
2024-05-07
Recruiting
The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer
NCT06368063Pancreatic Cancer Resectable
Xi'an Jiaotong University
Phase 4
642
Xi'an
2024-05-06
Recruiting
A Clinical Study on Evaluating Intravenous Administration of IDOV-SAFE
NCT06380309Advanced Malignant Solid Tumor of Digestive System
Peking University
Phase EARLY_PHASE1
89
Beijing
2024-05-06
Recruiting
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
NCT06238622Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis
Boehringer Ingelheim
Phase 3
1,700
Beijing, Changsha, Chengdu, Guangzhou, Hangzhou, Hefei, Hohhot, Jiaxing
2024-05-06
Active, closed
HRS9531 Injection in Obese Subjects With Heart Failure With Preserved Ejection Fraction
NCT06391710Heart Failure With Preserved Ejection Fraction
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 2
203
Beijing
2024-05-06
Recruiting
Efficacy of TEAS on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy
NCT06341270Liver Cancer
West China Hospital
Not applicable
524
Chengdu
2024-05-06
Not yet open
Study of Fruquintinib Combined With Tegafur Gimeracil Oteracil in Patients With Metastatic Colorectal Cancer
NCT06255379Metastasis Colorectal Cancer, Colon Cancer, Rectal Cancer
Guangzhou University of Traditional Chinese Medicine
Phase 2
52
Guangzhou
2024-05-06
Recruiting
Adding Of Naxitamb In Induction Therapy For High Risk Neuroblastoma
NCT06574698Neuroblastoma, GD2 Antibody (Naxitamab)
Guangzhou Women and Children's Medical Center
Observational
64
Guanzhou
2024-05-06
Recruiting
The Clinical Study of Post-operative Proton Radiotherapy for Thymus Tumor
NCT06311968Thymus Epithelial Tumor, Proton Radiotherapy, Radiation Toxicity
Jian Chen
Phase 2
55
Shanghai
2024-05-06
By invitation
A Prospective, Randomized, Open, Parallel-controlled, Superior-efficacy Clinical Study of Radical Sigmoidectomy for Sigmoid Cancer Versus Radical Sigmoidectomy Combined with Indocyanine Green Fluorescence Imaging Lymphatic Tracing Dissection in the Treatment of Sigmoid Cancer
NCT06396806Sigmoid Cancer
Sun Yat-sen University
Not applicable
1,072
Guangzhou
2024-05-06
Not yet open
A Study on the Safety and Preliminary Efficacy of NK042 in the Treatment of Malignant Ascites
NCT06415500Gynecologic Cancer
Anhui Provincial Hospital
Phase 1
9
Hefei
2024-05-06
By invitation
Intensive Adjuvant Therapy for TNBC with BRCA Gene Mutation
NCT06405295Breast Carcinoma, BRCA Mutation, Adjuvant Drug Therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
600
Beijing
2024-05-06
By invitation
Effect of (neo)Adjuvant Therapy on Lipids in Young Breast Cancer Patients
NCT06405269Breast Neoplasms, Lipid Profile
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
600
Beijing
2024-05-06
Recruiting
A Clinical Study of CHT102 in Mesothelin Positive Advanced Solid Tumors
NCT06717022Mesothelin Positive Tumors
Tianjin Medical University Cancer Institute and Hospital
Not applicable
24
Tianjin
2024-05-06
Recruiting
Neoantigen Vaccine Plus Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma After Radical Resection
NCT06406816Intrahepatic Cholangiocarcinoma
Yongyi Zeng
Phase EARLY_PHASE1
10
Fuzhou
2024-05-06
Not yet open
A Correlation Study of Cognitive Function in Patients With Depression
NCT05396989Depression
Central South University
Observational
200
Changsha
2024-05-06
Recruiting
Bortezomib, Pomalidomide, Dexamethasone for Systemic AL Amyloidosis
NCT06342466Systemic Amyloidosis
Jin Lu, MD
Phase 2
40
Beijing
2024-05-06
Active, closed
A Phase II Clinical Trial of Flonoltinib Maleate Tablet in Intermediate-High Risk Myelofibrosis
NCT06457425MF,PMF,PPV-MF,PET-MF
Chengdu Zenitar Biomedical Technology Co., Ltd
Phase 2
75
Chengdu, Tianjin
2024-05-06
By invitation
Unique Electroencephalography (EEG) Markers of Habit Behaviors in Obsessive-Compulsive Disorder (OCD)
NCT06882902Obsessive-Compulsive Disorder
Shanghai Mental Health Center
Not applicable
35
Shanghai
2024-05-05
Not yet open
Clinical Study on Prognosis of Patients With Severe NPDR Undergoing Vitrectomy
NCT05852132Non Proliferative Diabetic Retinopathy(NPDR)
Fei Gao
Not applicable
249
Tianjin
2024-05-05
Recruiting
Peripheral-central Correlation Study on the Treatment of Chronic Tinnitus With "Dao qi Tong Luo" Based on the Theory of "Connecting the Two Ears to the Brain"
NCT06401993Tinnitus
The Third Affiliated hospital of Zhejiang Chinese Medical University
Not applicable
87
Hangzhou
2024-05-04
Recruiting
Dalpiciclib in HR+/HER2- ABC
NCT06301438Advanced Breast Cancer
RenJi Hospital
Observational
103
Shanghai
2024-05-03
Active, closed
A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015)
NCT06356311Gastroesophageal Cancer
Merck Sharp & Dohme LLC
Phase 3
450
Hefei, Chongqing, Fuzhou, Xiamen, Guangzhou, Shantou, Nanning, Shijiazhuang
2024-05-03
Not yet open
PK/PD Study of Anti-Infective Drugs in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation Treatment
NCT06319677Critical Illness, Extracorporeal Membrane Oxygenation Complication
The Third Xiangya Hospital of Central South University
Observational
50
Changsha
2024-05-01
Active, closed
N-Acetylcysteine as Therapy for Transplantation- Associated Thrombotic Microangiopathy
NCT07279610Thrombotic Microangiopathy
The First Affiliated Hospital of Soochow University
Phase 2/3
44
Suzhou
2024-05-01
Recruiting
Analysis of Tumor Deposit at the Fusion Site of the Right Gastric Mesentery and Left Gastric Mesentery in the Patients With Gastric Cancer Who Received Proximal Gastrectomy
NCT06728891Gastric Carcinoma
Jichao Qin
Observational
100
Hangzhou
2024-05-01
Recruiting
Lymph Node Metastasis in Early Esophageal Squamous Cell Carcinoma
NCT07050576ESCC, Lymph Node Metastasis, Radiomics
The First Affiliated Hospital of Anhui Medical University
Observational
500
Hefei
2024-05-01
Recruiting
BAI-BACE for Advanced Lung Squamous Cell Carcinoma
NCT06377735Squamous Cell Carcinoma
Sun Yat-sen University
Not applicable
85
Beijing
2024-05-01
Recruiting
Micro-movements in Patients With Prolonged Disorders of Consciousness
NCT06406413Consciousness Disorders
First Affiliated Hospital of Zhejiang University
Observational
179
Hanzhou
2024-05-01
Not yet open
Concomitant Tricuspid Repair in Patients With Left Heart Surgery
NCT05595187Tricuspid Regurgitation, Mitral Regurgitation, Cardiopulmonary Bypass
Nanjing Medical University
Not applicable
400
Nanjing
2024-05-01
Recruiting
A Functional Near- Infrared Spectroscopy Study on the Brain Activation Characteristics of Stroke Patients During Mirror Movement
NCT07509944Stroke, Upper Limb Function
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
25
Hangzhou
2024-05-01
Active, closed
Clinical Study on the Impact of Eradication of Oral Porphyromonas Gingivalis on the Prognosis of Early Esophageal Cancer After ESD Surgery
NCT06722300Esophageal Cancer
The First Affiliated Hospital of Henan University of Science and Technology
Not applicable
856
Luoyang
2024-05-01
By invitation
Personalized Brain Stimulation for Cognitive Impairment in Older Adults
NCT07208734Alzheimer s Disease
Xuanwu Hospital, Beijing
Not applicable
460
Beijing
2024-05-01
Recruiting
Whole Genome Sequencing Versus Whole Exome Sequencing for Congenital Diarrhea and Enteropahty
NCT04528303Diarrhea, Infantile, Enteropathy
Children's Hospital of Fudan University
Not applicable
180
Shanghai
2024-05-01
Not yet open
Linperlisib Plus Obinutuzumab and Venetoclax for Relapsed and Refractory Blastoid Variant of Mantle Cell Lymphoma.
NCT06324994Mantle Cell Lymphoma
Dalian Medical University
Phase 2
10
Dalian
2024-05-01
Rows per page Showing 12801–12900 of 19052
Previous 127 128 129 130 131 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=129

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.